Risk factors in the early diagnosis of ALS: North American epidemiological studies

References

• Gaziano JM, Sesso HD, Breslow JL, Hennekens CH, Buring JE. Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. Am J Cardiol 1999; 84: 768–773.
   PubMed Web of Science ®Google Scholar
• Whisnant JP, Brown RD, Petty GW, O’Fallon WM, Sicks JD, Wiebers DO. Comparison of population-based models of risk factors for TIA and ischemic stroke. Neurology 1999; 53: 532–536.
   PubMed Web of Science ®Google Scholar
• Chiò A. Risk factors in the early diagnosis of ALS: European epidemiological studies. ALS 2000; 1 (Suppl 1): S13–S18.
   Google Scholar
• Kaplan GA, Haan MN. Wallace RB. Understanding changing risk factor associations with increasing age in adults. Ann Rev Public Health 1999; 20: 89–108.
   PubMed Web of Science ®Google Scholar
• Brooks BR. Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 1996; 14: 399–420.
   PubMed Web of Science ®Google Scholar
• Preux PM, Couratier P, Boutros-Toni F et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996; 15: 153–160.
   Google Scholar
• Ringel SP, Murphy JR, Alderson MK et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–1322.
   Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyo- trophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118(Pt 3): 707–719.
   Google Scholar
• Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996; 47(4 Suppl 2): S71–S81; discussion S81–S82.
   Google Scholar
• Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160 (Suppl 1): S37–S41.
   PubMed Web of Science ®Google Scholar
• Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66–72.
   PubMed Web of Science ®Google Scholar
• Anderson FA Jr, Miller RG. ALS CARE: a resource for measuring and improving ALS outcomes. Neurology 1996; 47 (4 Suppl 2): S113–S115; discussion S115–S116.
   Google Scholar
• Jenkinson C, Swash M, Fitzpatrick R. The European Amy- otrophic Lateral Sclerosis Health Profile Study. ALS-HPS Steering Group. J Neurol Sci 1998; 160 (Suppl 1): S122–S126.
   PubMedGoogle Scholar
• Annegers JF, Appel S, Lee JR, Perkins P. Incidence and preva- lence of amyotrophic lateral sclerosis in Harris County, Texas, 1985–1988. Arch Neurol 1991; 48: 589–593.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986; 5: 61–70.
   Google Scholar
• McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996; 47: 571–573.
   PubMed Web of Science ®Google Scholar
• Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989; 42: 569–575.
   PubMed Web of Science ®Google Scholar
• Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990; 47: 38–41.
   Google Scholar
• Armon C, Kurland LT, Daube JR, O’Brien PC. Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991; 1: 1077–1084.
   Google Scholar
• Cruz DC, Nelson LM, McGuire V, Longstreth WT Jr. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case- control study. Neuroepidemiology 1999; 18: 101–110.
   PubMed Web of Science ®Google Scholar
• Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998; 55: 201–206.
   PubMedGoogle Scholar
• McGuire V, Longstreth WT Jr, Nelson LM et al. Occupational exposures and amyotrophic lateral sclerosis. A population- based case-control study. Am J Epidemiol 1997; 145: 1076–1088.
   Google Scholar
• Deapen DM, Henderson BE. A case-control study of amyo- trophic lateral sclerosis. Am J Epidemiol 1986; 123: 790–799.
   PubMed Web of Science ®Google Scholar
• Johansen C, Olsen JH. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol 1998; 148: 362–368.
   PubMed Web of Science ®Google Scholar
• Nelson LM. Epidemiology of ALS. Clin Neurosci 1995–96; 3: 327–331.
   Google Scholar
• Savitz DA, Loomis DP, Tse CK. Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 1998; 53: 71–74.
   Google Scholar
• Savitz DA, Checkoway H, Loomis DP. Magnetic field exposure and neurodegenerative disease mortality among electric utility workers. Epidemiology 1998; 9: 398–404.
   PubMed Web of Science ®Google Scholar
• Nicholas JS, Lackland DT, Dosemeci M et al. Mortality among US commercial pilots and navigators. J Occup Environ Med 1998; 40: 980–985.
   PubMed Web of Science ®Google Scholar
• Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995; 132: 207–215.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Sub- committee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci 1994; 124 (Suppl): 96–107.
   Google Scholar
• Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990–2040. Neuroepidemiol- ogy 1994; 13: 179–186.
   PubMed Web of Science ®Google Scholar